PTH-072 Corticosteroid Dose Reduction in Ulcerative Colitis Patients Treated with Vedolizumab

IntroductionCorticosteroids (CS) are effective for the short-term treatment of patients (pts) with ulcerative colitis (UC), but serious side effects prohibit long-term use. In the GEMINI 1 study, a higher percentage of pts with moderately to severely active UC were in CS-free remission at week (wk)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut 2016-06, Vol.65 (Suppl 1), p.A254
Hauptverfasser:	Loftus, E, Siegel, C, Panaccione, R, Sandborn, W, Smyth, M, James, A, Xu, J, Abhyankar, B
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Corticosteroids Induction therapy Inflammatory bowel disease Monoclonal antibodies Parathyroid hormone Patients Pharmaceuticals Prednisone Remission Tumor necrosis factor Tumor necrosis factor-TNF Tumors Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!